Treatment of methadone-induced torsades de pointes with lidocaine

J La State Med Soc. 2013 Nov-Dec;165(6):338-41.

Abstract

Methadone maintenance treatment (MMT) is commonly used for chronic pain control and for substitution in heroin addicts undergoing rehabilitation. Methadone is known to prolong QT interval and sometimes cause torsade de pointes (TdP) and ventricular fibrillation (VF). Treatment of TdP by antiarrhythmic drugs that prolong QT interval may worsen TdP. To our knowledge, worsening of methadone-induced TdP by amiodarone has not been reported before. We describe here a case of methadone-induced TdP that deteriorated into ventricular fibrillation upon treatment with intravenous (IV) amiodarone and resolved after discontinuation of amiodarone and treatment with IV magnesium, potassium, and lidocaine.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Arrhythmia Agents / administration & dosage
  • Anti-Arrhythmia Agents / therapeutic use*
  • Electrocardiography
  • Female
  • Humans
  • Lidocaine / administration & dosage
  • Lidocaine / therapeutic use*
  • Methadone / adverse effects*
  • Methadone / therapeutic use
  • Opiate Substitution Treatment / methods
  • Opioid-Related Disorders / drug therapy
  • Torsades de Pointes / chemically induced*

Substances

  • Anti-Arrhythmia Agents
  • Lidocaine
  • Methadone